Companies developing stem cell-based interventions should work with policymakers and patient advocates to address risks for current and future patients and to protect clinical research and the reputation of the field, write the authors. Read their full article in Cell & Gene Therapy Insights (free registration).
It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.
Kirstin R.W. Matthews, Ana S. Iltis, Daniel S. Wagner, Nuria Gallego Marquez, Jason Scott Robert, Inmaculada de Melo-Martín, Marieke Bigg, Sarah Franklin, Soren Holm, Ingrid Metzler, Matteo A. Molè, Jochen Taupitz, Giuseppe Testa, Jeremy SugarmanFebruary 26, 2021
Existing innovation in outcomes measurement and resource management, coupled with the competitive pressures of Covid-19, create a unique window for value creation within surgical care, the authors write. Read their article in the Annals of Surgery.
Anaeze C. Offodile II, Kushal T. Kadakia, Lee Fleisher, C.J. Stimson, Thomas AloiaJuly 26, 2020
Expanded “payment bundles” for the treatment of end stage kidney disease did not in general increase the risk of closure by dialysis facilities, the authors conclude.
Sayna Norouzi, Bo Zhao, Ahmed Awan, Wolfgang Winkelmayer, Vivian Ho, Kevin EricksonFebruary 5, 2020
Federal mandates have affected nearly all areas of dialysis care delivery. Nonresident scholar Kevin F. Erickson and Wolfgang C. Winkelmayer evaluate the evidence behind two prior federal mandates to assess how the quality of evidence supporting each policy contributed to its overall success.
Kevin Erickson, Wolfgang WinkelmayerNovember 30, 2018
The authors compare views on the relationship between faith and health for two groups that are overrepresented in American Christianity and underrepresented in medical careers (African Americans and Latinos) with a group that is similarly religious but comparatively well-represented in medical professions (Korean Americans).
Daniel Bolger, Cleve Tinsley IV, Elaine Howard EcklundNovember 28, 2017
The authors investigate whether stance of a religious tradition toward capitalism will help shape individual scientists’ views on science commercialization and whether the religious tradition of scientists correlates with their attitude toward the commercialization of science.
Jared L. Peifer, David R. Johnson, Elaine Howard EcklundOctober 23, 2017
Data from a survey of 892 scientists in Taiwan demonstrate that while scientists perceive religion and scientific research as generally separate in the abstract, in practice, they regard the boundary between religion and their workplace as somewhat permeable.
Both black Americans and Latinos have concerns about science teachers being biased. Yet, the groups differ in their assessment of the danger of anti-religious bias, according to findings by the authors. Published by Review of Religious Research.
Daniel Bolger, Elaine Howard EcklundOctober 3, 2017
Drawing on a nationally representative survey of US adults, the authors examine what factors — when individuals have a question about science — shape respondent’s likelihood of turning to science-based versus religion-based sources.
Christopher Scheitle, David R. Johnson, Elaine Howard EcklundJuly 12, 2017